Verastem (VSTM) Total Liabilities (2011 - 2026)
Verastem (VSTM) recorded quarterly Total Liabilities of $146.0 million in Q1 2026, down 22.83% quarter-over-quarter from $189.2 million in Q4 2025, and down 11.03% on a YoY basis from $164.1 million in Q1 2025.
Verastem (VSTM) Total Liabilities (2011 - 2026) Analysis & Trends
Verastem's Total Liabilities history runs 16 years deep, the most recent figure standing at $146.0 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 11.03% year-over-year to $146.0 million; the TTM figure through Mar 2026 stood at $146.0 million (down 11.03% YoY), while the FY2025 annual figure was $189.2 million, up 45.09% from the prior year.
- Total Liabilities was $146.0 million for Q1 2026 at Verastem, down from $189.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $192.4 million in Q3 2025 to a low of $43.4 million in Q1 2022.
- Historically, Total Liabilities has averaged $99.1 million across 5 years, with a median of $71.8 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Total Liabilities jumped 197.26% in 2022, then decreased 11.03% in 2026.
- A 5-year view of Total Liabilities shows it stood at $47.7 million in 2022, then soared by 49.36% to $71.2 million in 2023, then soared by 83.23% to $130.4 million in 2024, then surged by 45.09% to $189.2 million in 2025, then declined by 22.83% to $146.0 million in 2026.
- The last three Total Liabilities figures came in at $146.0 million (Q1 2026), $189.2 million (Q4 2025), and $192.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 146.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 146.03 Mn |
| Dec 31, 2025 | 189.25 Mn |
| Sep 30, 2025 | 192.38 Mn |
| Jun 30, 2025 | 160.21 Mn |
| Mar 31, 2025 | 164.13 Mn |
| Dec 31, 2024 | 130.43 Mn |
| Sep 30, 2024 | 94.16 Mn |
| Jun 30, 2024 | 65.74 Mn |
| Mar 31, 2024 | 77.32 Mn |
| Dec 31, 2023 | 71.19 Mn |
| Sep 30, 2023 | 71.81 Mn |
| Jun 30, 2023 | 69.01 Mn |
| Mar 31, 2023 | 66.69 Mn |
| Dec 31, 2022 | 47.66 Mn |
| Sep 30, 2022 | 48.22 Mn |
| Jun 30, 2022 | 46.52 Mn |
| Mar 31, 2022 | 43.38 Mn |
| Dec 31, 2021 | 21.10 Mn |
| Sep 30, 2021 | 16.22 Mn |
| Jun 30, 2021 | 35.69 Mn |